Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235

被引：0
|
作者：
Jose G. Bazan
Fenghai Duan
Bradley S. Snyder
Dunstan Horng
Edward E. Graves
Barry A. Siegel
Mitchell Machtay
Billy W. Loo
机构：
[1] The Ohio State University,Department of Radiation Oncology
[2] Brown University School of Public Health,Department of Biostatistics and Center for Statistical Sciences
[3] Brown University School of Public Health,Center for Statistical Sciences
[4] ECOG-ACRIN Cancer Research Group,Department of Radiation Oncology, Stanford Cancer Institute, School of Medicine
[5] Stanford University,Mallinckrodt Institute of Radiology and the Siteman Cancer Center
[6] Washington University School of Medicine,Case Comprehensive Cancer Center and Case Western Reserve University
[7] University Hospitals Seidman Cancer Center,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2017年 / 44卷
关键词：
Metabolic tumor volume; FDG-PET; NSCLC; SUV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：17 / 24
页数：7
相关论文
共 50 条
  • [1] Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235
    Bazan, Jose G.
    Duan, Fenghai
    Snyder, Bradley S.
    Horng, Dunstan
    Graves, Edward E.
    Siegel, Barry A.
    Machtay, Mitchell
    Loo, Billy W., Jr.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (01) : 17 - 24
  • [2] Metabolic Tumor Volume Predicts Overall Survival in Patients With Stage III Non-Small Cell Lung Cancer Treated on ACRIN 6668/RTOG 0235
    Bazan, J. G.
    Duan, F.
    Snyder, B. S.
    Horng, D.
    Graves, E. E.
    Siegel, B. A.
    Machtay, M.
    Loo, B. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S3 - S4
  • [3] Pretreatment FDG-PET Metrics in Stage III Non-Small Cell Lung Cancer: ACRIN 6668/RTOG 0235
    Ohri, Nitin
    Duan, Fenghai
    Machtay, Mitchell
    Gorelick, Jeremy J.
    Snyder, Bradley S.
    Alavi, Abass
    Siegel, Barry A.
    Johnson, Douglas W.
    Bradley, Jeffrey D.
    DeNittis, Albert
    Werner-Wasik, Maria
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (04):
  • [4] Metabolic Tumor Volume on FDG-PET Predicts Clinical Outcomes Following Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of ECOG-ACRIN 6668/RTOG 0235
    Ohri, N.
    Duan, F.
    Machtay, M.
    Gorelick, J. J.
    Snyder, B. S.
    Alavi, A.
    Siegel, B.
    Johnson, D. W.
    Bradley, J. D.
    DeNittis, A. S.
    Werner-Wasik, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S17 - S17
  • [5] Metabolic Tumor Volume on FDG-PET Predicts Clinical Outcomes Following Chemoradiation Therapy for Locally-Advanced Non-small Cell Lung Cancer: A Secondary Analysis of ECOG-ACRIN 6668 / RTOG 0235
    Ohri, N.
    Duan, F.
    Machtay, M.
    Gorelick, J. J.
    Snyder, B. S.
    Alavi, A.
    Siegel, B.
    Johnson, D. W.
    Bradley, J. D.
    DeNittis, A. S.
    Werner-Wasik, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S144 - S145
  • [6] Metabolic tumor volume predicts overall survival in lung cancer patients treated definitively
    Lee, P.
    Bazan, J. G.
    Weerasuriya, D. K.
    Lavori, P. W.
    Quon, A.
    Le, Q.
    Loo, B. W., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S462 - S462
  • [7] Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial
    Ali Salavati
    Fenghai Duan
    Bradley S. Snyder
    Bo Wei
    Sina Houshmand
    Benjapa Khiewvan
    Adam Opanowski
    Charles B. Simone
    Barry A. Siegel
    Mitchell Machtay
    Abass Alavi
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1969 - 1983
  • [8] Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial
    Salavati, Ali
    Duan, Fenghai
    Snyder, Bradley S.
    Wei, Bo
    Houshmand, Sina
    Khiewvan, Benjapa
    Opanowski, Adam
    Simone, Charles B., II
    Siegel, Barry A.
    Machtay, Mitchell
    Alavi, Abass
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (12) : 1969 - 1983
  • [9] Gross Target Volume as the Predictor for the Overall Survival for Stage III Non-Small Cell Lung Cancer
    Sun, J.
    Zhang, X.
    Chang, J. Y.
    Gomez, D.
    Jiang, S.
    Wang, P.
    Yuan, Z.
    Zhao, L.
    Wang, L.
    Hui, Z.
    Liao, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S642 - S643
  • [10] Gross Target Volume as the Predictor for the Overall Survival for Stage III Non-Small Cell Lung Cancer
    Sun, J.
    Zhang, X.
    Chang, J. Y.
    Gomez, D.
    Jiang, S.
    Wang, P.
    Yuan, Z.
    Zhao, L.
    Wang, L.
    Hui, Z.
    Liao, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S21 - S21
12345